HERON THERAPEUTICS, INC. /DE/ — Director's Dealing 2025

Feb 4, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HERON THERAPEUTICS, INC. /DE/ (HRTX)
CIK: 0000818033
Period of Report: 2025-01-31

Reporting Person: Forbes William P (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-31	Employee Stock Option (Right to Buy)	$1.7	A	374220	Acquired	2035-01-31	Common Stock (374220)	Direct
2025-01-31	Restricted Stock Units	$0	A	187110	Acquired		Common Stock (187110)	Direct

Footnotes

F1: The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (January 31, 2025).

F2: The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025).